Friday, 13 February 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 13 February 2026
News

AZ eyes 25-plus blockbusters

Posted 13 February 2026 AM

AstraZeneca has doubled down on its target to deliver US$80 billion in total revenue by 2030, with plans to build a portfolio of more than 25 blockbusters by the end of the decade.

The British pharmaceutical giant capped 2025 with fourth-quarter revenues of US$15.5 billion, thanks to the company’s oncology portfolio which contributed US$7 billion to that figure.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (14)

Access & Reimbursement (1)

Clinical & Medical, R&D (6)

Regulatory, Pharmacovigilance & QA (5)

Other (18)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.